23.200
+0,87%
2026-10-19
Fundamental Analysis
94 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +72.0% | +61.9% | 3 / 3 | +46.6% | +5.89 pp | +4.87 pp | +25.7% | 1.12 | 3.35 | 785 | +46,6% | 201 | +81,1% | 3.35 | 6.66 | −49,7% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 6 | 12 | |||||||
Valuation annotation:Price: 23.200 (close price on 2026-10-19)EPS (TTM): 6.932
Financial charts
1.Revenue & growth
VND bn785Q2/26
1.Revenue & growth
VND bn785Q2/26
2.Profit & growth
VND bn178Q2/26
3.Profit mix (Penman)
VND bn722Q2/26
4.Margins & cost structure
%37.1%Q2/26
5.Returns & cash cycle
% · days15.6%Q2/26
6.Earnings quality & cash
VND bn308Q2/26
7.Asset structure
VND bn7.024Q2/26
8.Funding & debt health
VND bn · times7.024Q2/26
9.Revenue backlog
VND bn10,6Q2/26
10.Valuation
times · %3,3×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.121Q2/26
Adjusted EPS growth, latest quarter
72.0%
Average adjusted EPS growth, 3 quarters
61.9%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26